drugset / Trial / NCT02289274

Study to Compare Pharmacokinetic Characteristics of Eperisone and Aceclofenac With NVP-1203

NCT02289274

Phase 1 Withdrawn NVP Healthcare
RandomizedCrossoverOpen-labelTreatment

Summary

The purpose of this study is to compare the pharmacokinetics of NVP-1203 and coadministration of aceclofenac and eperisone HCl SR.

Timeline

Start
2019-11
Primary completion
2019-12
Completion
2019-12

Drugs

EvaluationDrugModalityDoseRoute
Comparator Aceclofenac Small molecule
Comparator Eperisone Small molecule
Subject NVP-1203 Unknown

Indications

No indication recorded.